XML 44 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Acquisition of Nora Pharma Inc. (Details Narrative)
12 Months Ended
Apr. 22, 2024
USD ($)
Apr. 22, 2024
CAD ($)
Oct. 20, 2022
USD ($)
shares
Dec. 31, 2025
USD ($)
Dec. 31, 2025
CAD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
CAD ($)
Mar. 31, 2026
USD ($)
Oct. 20, 2022
CAD ($)
Business Combination [Line Items]                  
Earnout payable       $ 295,797       $ 295,797  
Nora Pharma [Member]                  
Business Combination [Line Items]                  
Purchase price of shares     $ 18,860,637            
Payments to acquire shares     $ 14,346,637            
Stock issued for acquisition | shares     1,850            
Stock issued for acquisition, value     $ 4,514,000            
Earnout liability expense, first installment           $ 1,036,500 $ 1,426,914    
Earnout liability expense, second installment $ 2,247,400 $ 3,093,878              
Remaining earnout balance       $ 295,797 $ 479,208        
Nora Pharma [Member] | Malek Chamoun [Member]                  
Business Combination [Line Items]                  
Earnout payable     $ 3,632,000           $ 5,000,000